Focused Issue on Radiotherapy for Brain Metastases from Lung Cancer

Posted On 2019-06-21 08:14:01



This focused issue on “Focused Issue on Radiotherapy for Brain Metastases from Lung Cancer” is edited by Dr. Lucyna Kepka, Department of Radiation Oncology, Military institute of Medicine, Warsaw, Poland.

Dr. Kepka is the Head of the Department of Radiation Oncology, Military Institute of Oncology, Warsaw, Poland. Her main field of interest is radiotherapy of lung cancer and brain tumors with a major focus on brain metastases treatment. She organized and conducted national multicenter trials on postoperative radiotherapy in non-small cell lung cancer (NSCLC), radiotherapy of brain after surgery for brain metastases. Her single center prospective studies on hypofractionation in radiotherapy of NSCLC, the integration of PET-CT in radiotherapy with elective nodal irradiation for NSCLC have been published. She also actively cooperated with the IAEA in research on radiotherapy in developing countries.

Focused issue outline:

  1. Introduction to this focused issue
    Lucyna Kepka, Department of Radiation Oncology, Military institute of Medicine, Warsaw, Poland
  2. Radiotherapy of brain metastases from lung cancer with presence of driver mutation EGFR or ALK
    Goetz Kloecker, James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, USA
  3. Combination of immunotherapy and radiotherapy in treatment of brain metastases from NSCLC
    Helen A Shih, Massachusetts General Hospital, Boston, USA
  4. WBRT in brain metastases from NSCLC: prevention of neurotoxicity
    Jose Belderbos, The Netherlands Cancer Institute, Amsterdam, the Netherlands
  5. Hippocampal avoidance in prophylactic cranial irradiation for SCLC: benefits and pitfalls
    Wilson Roa, University of Alberta, Edmonton, Canada
  6. WBRT for brain metastases from lung cancer: for whom and when? Contemporary point of view
    Beata Sas-Korczyńska, Military Institute of Medicine, Warsaw, Poland
  7. Evidence-based best supportive care for brain metastases from lung cancer
    Maciej M Mrugala, Mayo Clinic, Rochester, USA
  8. Re-irradiation of brain metastases from lung cancer
    Carsten Nieder, University of Tromsø, Tromsø, Norway
  9. Radiotherapy for brain metastases from SCLC in distinct clinical indications and scenarios
    Lucyna Kepka, Military Institute of Medicine, Warsaw, Poland
  10. Prophylactic cranial irradiation in NSCLC: evidence and future development
    Justyna Chalubinska-Fendler, Military Institute of Medicine, Warsaw, Poland
  11. Local ablative therapy of brain metastases from NSCLC: benefits and limitations
    Douglas Guedes de Castro, AC Camargo Cancer Center, Sao Paulo, Brazil
  12. Management of multiple and/or large brain metastases from NSCLC
    Emilie Le Rhun, Centre Hospitalier Universitaire de Lille, Lille, France
  13. Technological advancement in imaging and radiotherapy in modern management of brain
    metastases from lung cancer Stephanie Combs, Technical University of Munich, Munich, Germany
  14. Management of brain metastases in elderly patients with lung cancer
    Joanna Socha, Military Institute of Medicine, Warsaw, Poland
  15. Prognostic and predictive factors in brain metastases from lung cancer
    Jai Prakash Agarwal, Tata Memorial Hospital, Parel, Mumbai, India
  16. Prognostic and predictive factors in brain metastases from lung cancer
    Gregory M Videtic, Cleveland Clinic Foundation, Cleveland, Ohio, USA